The extracellular matrix (ECM) is a group of molecules that offer structural and biochemical support to cells and interact with them to regulate their function. Also, growth factors (GFs) stored in the ECM can be locally released during ECM remodeling. Here, we hypothesize that the balance between ECM components and remodelers is regulated according to the ovarian steroid milieu to which the oviduct is exposed during the periovulatory period. Follicular growth was manipulated to generate cows that ovulated small follicles (SF-small corpus luteum [SCL]; n = 20) or large follicles (LF-large corpus luteum [LCL]; n = 21) and possess corresponding Estradiol (E2) and Progesterone (P4) plasmatic concentrations. Ampulla and isthmus samples were collected on day 4 (day 0 = ovulation induction) and immediately frozen or fixed. The transcriptional profile (n = 3/group) was evaluated by RNA sequencing. MMP Antibody Array was used to quantify ECM remodelers' protein abundance and immunohistochemistry to quantify type I collagen. Transcriptome analysis revealed the over-representation of ECM organization and remodeling pathways in the LF-LCL group. Transcription of ECM components (collagens), remodelers (ADAMs and MMPs), and related GFs were upregulated in LF-LCL. Protein intensities for MMP3, MMP8, MMP9, MMP13, and TIMP4 were greater for the LF-LCL group. Type I collagen content in the mucosa was greater in SF-SCL group. In conclusion, that the earlier and more intense exposure to E2 and P4 during the Oviductal extracellular matrix, 2018, Vol. 99, No. 3 591 periovulatory period in LF-LCL animals stimulates ECM remodeling. We speculate that differential ECM regulation may contribute to oviductal receptivity to the embryo.
Introduction
An adequate environment for fertilization and early embryonic development is provided by the oviduct [1, 2] , which depends on the sex-steroid endocrine milieu for its proper function [3, 4] . For example, under an estradiol stimulus the oviductal epithelial cells increase proliferation and secretion of micro and macromolecules that change the oviductal luminal micro environment [5] [6] [7] . Previous assessment of the oviductal transcriptome has revealed a number of genes regulated by the periovulatory endocrine milieu [8] . This suggested a relevant role of proestrus-estrus estradiol (E2) and metaestrus-diestrus progesterone (P4) concentrations in regulating oviductal function. Enriched pathways included cellular proliferation, secretion, and extracellular matrix (ECM) remodeling. Additionally, it was reported recently that the sex steroid-mediated changes in the oviductal transcriptome were intimately associated with variations in oviductal morphology. Specifically, cows ovulating larger follicles presented a greater number of secretory cells and oviductal folds, greater proportion of proliferating cells, and greater epithelial area when compared to cows ovulating smaller follicles [9] . Collectively, global transcriptional regulation and phenotypic changes of oviductal tissue may help to explain the positive impact of a larger preovulatory follicle (POF) size on fertility during timed artificial insemination protocols [10] [11] [12] . However, sex-steroid effects on oviductal ECM remodeling dynamics in cattle are poorly understood.
The ECM is an arrangement of extracellular molecules that offer structural and biochemical support to cells and tissues [13, 14] . ECM interacts with the surrounding cells and signals to regulate important processes such as migration, proliferation, apoptosis, and/or differentiation of cells. Also, growth factors (GFs) can be stored in the ECM and released locally during the remodeling process through ECM cleavage [13, 15, 16] . Growth factors identified in the ECM include epidermal growth factor (EGF), fibroblast growth factor (FGF), WNTs, transforming growth factor-β (TGFB), and amphiregulin [17] . Furthermore, GFs play a central role in the regulation of ECM remodeling itself by promoting cellular proliferation. ECM remodeling regulation is complex and depends on a balance of abundance and activity of specific matrix proteinases and their inhibitors [15, 17] . Endometrial ECM remodeling during embryo implantation has been described in humans, mice, and ruminants [18] [19] [20] . Furthermore, we showed clear effects of the periovulatory sex-steroid concentrations in the remodeling of the endometrial ECM [21] .
Here, we hypothesize that the balance between abundance of ECM components and remodelers is regulated according to the ovarian steroid milieu to which the oviduct is exposed during the periovulatory period.
Materials and methodology

Animals
Animal procedures were approved by the Ethics Committee on Animal Use of the School of Veterinary Medicine and Animal Science of the University of São Paulo (CEUA/FMVZ; protocols numbers 2281-2011 and 4293160916). Experiments were conducted at the University of São Paulo, Pirassununga campus (Brazil) using adult, pluriparous, cyclic, and nonlactating Nelore (Bos indicus) cows, without reproductive disorders, according to gynecological examinations, and body condition scores between 3 and 4 (0 emaciated; 5 obese). All animals were kept in grazing conditions and to fulfill their maintenance requirements, they were supplemented with sugar cane and/or corn silage, concentrate, minerals, and water ad libitum.
Reproductive management and experimental design
Ovulations were synchronized as described previously by Mesquita et al. [22] and Gonella et al. [8] . Cows were manipulated to ovulate smaller [small follicle-small corpus luteum (CL) group (SF-SCL)] or larger [large follicle-large CL group (LF-LCL)] follicles. Our previous studies have reported contrasting periovulatory endocrine milieus with distinct proestrus/estrus concentrations of E2 and metaestrus concentrations of P4, as well as different receptivity and fertility between the above-mentioned experimental groups [8, 10, 22, 23] . Briefly, animals were presynchronized by two intramuscular (im) injections of prostaglandin F2α analog (PGF; 0.5 mg of sodium cloprostenol; Sincrocio, Ourofino Saúde Animal, Cravinhos, Brazil), 14 days apart. At the second PGF injection of Presynch (D-20), animals received an Estrotect Heat detector patch device (Rockway, Inc., Spring Valley, WI, USA), and estrus detection was performed twice a day every day from D-19 to D-10. Only animals that presented estrus after the second PGF treatment and with a new PGF-responsive CL (at least 5 days old) on D-10 stayed in the experiment. On D-10, the remaining cows (n = 41) received a new intravaginal P4-releasing device (1 g; Sincrogest, Ourofino) and an im injection of 2 mg estradiol benzoate (Sincrodiol, Ourofino Saúde Animal; Figure 1 ). On D-10, cows were assigned randomly to receive nothing (SF-SCL) or a single im injection of PGF (LF-LCL group). Eight days later, the P4 devices were removed 42-60 h or 30-36 h before the gonadotropinreleasing hormone (GnRH) treatment in the LF-LCL (n = 20) and SF-SCL (n = 21) groups, respectively. All animals received a PGF injection at P4 device removal. Ovulations were induced in all cows on D0 using GnRH agonist (Buserelin acetate, 10 μg, im; Sincroforte, Ourofino Saúde Animal). Expectation was that POF growth would be reduced in the presence of greater circulating P4 concentrations in cows from the SF-SCL group due to both exogenous (device) and endogenous (CL) P4 sources.
To assess follicle growth and ovulation of the POF as well as CL area and blood flow, transrectal ultrasound examinations were carried out on D-10 and D-6, and daily from D-2 to D4. Ultrasound exams were performed with the aid of a duplex B-mode (gray-scale) and Color-Doppler instrument (MyLab30 Vet Gold; Esaote Healthcare, São Paulo, SP, Brazil) equipped with a multi-frequency linear transducer. Blood samples were collected via jugular venipuncture in tubes containing heparin (BD, São Paulo, SP, Brazil) on D-1 and D4. Blood samples were immediately stored on ice. To obtain plasma, blood was centrifuged at 1500× g for 30 min (min) at 4
• C. The plasma was then aliquoted and stored at −20 • C. To remain in the experiment, animals had to fulfill the following premises: POF diameter on D0 greater than 8 mm, ovulation detected after D0 or before D3, and no presence of follicular or luteal cysts at any moment during the experiment. After fulfilling these criteria, 24 animals were selected (LF-LCL, n = 16; SF-SCL, n = 8). On D4 of the estrous cycle (day 0 = injection of GnRH to induce ovulation), cows were stunned by a captive bolt and slaughtered by jugular exsanguination. The reproductive tract was transported on ice to the laboratory, ovarian structures were measured and weighed, and the oviduct ipsilateral to the ovary bearing the CL was dissected. Samples from ampulla and isthmus were snap-frozen in liquid nitrogen and stored at −80 • C until RNA or protein extraction. Tissue samples were also fixed by immersion in 10% neutral buffered formalin for 24 h at 4 • C, followed by several washings in PBS. Subsequently, samples were embedded in paraffin.
Hormonal quantification
Concentrations of P4 were measured by radioimmunoassay (Coat-A-Count kit progesterone, Siemens Medical Solutions Diagnostics) validated previously for bovine plasma samples [24] . Estradiol concentrations were measured using a commercial RIA kit (Double Antibody Estradiol, DPC, Los Angeles, CA, USA) validated previously for bovine plasma samples [25] . The intra-assay CV and sensitivity were 1.7% and 0.13 pg/mL for E2 and 0.8% and 0.05 ng/mL for P4, respectively.
RNA extraction
Total RNA was extracted using the kit AllPrep DNA/RNA/Protein Mini kit (No. 80004, Qiagen, São Paulo, São Paulo, Brazil). Frozen ampulla and isthmus samples were ground in liquid nitrogen using a mortar and pestle, and were mixed with buffer RLT. Tissue suspension was homogenized with a 21-g needle, centrifuged at 13 000× g for 3 min and supernatant was loaded and processed in silica columns. Columns were eluted with 30 μL of RNase-free water, and RNA was kept at −80 • C. Concentration of total RNA extracts was measured using the Nano-Vue spectrophotometer (GE Healthcare Europe, Munich, Germany).
mRNA libraries, sequencing, and bioinformatics
Methods and general results from transcriptomic analysis of tissues were published previously [8, 26] . Briefly, ampulla and isthmus samples from three animals of each group were selected for individual RNA-Seq (please see details in the Statistical Analyses section). Only samples with an RIN ≥ 8 were considered suitable for RNAseq analysis (Agilent Bioanalyzer, Agilent Technologies, Palo Alto, USA).
Libraries were generated according to the protocols developed by Illumina Technologies using 1 μg of total RNA as input (TruSeq, Illumina Technologies, San Diego, CA). Briefly, polyA-selected RNA was cleaved and fragments were used to generate first-strand cDNA using SuperScript II reverse transcriptase and random hexamers. Next, RNaseH and DNA polymerase enzyme were used to generate the second cDNA strand and immediately adapter ligation and end repair steps were performed. Resulting products were amplified using PCR and cDNA libraries were then purified and validated using the Bioanalyzer 2100 (Agilent Technologies). The Illumina HiSeq 2000 (ampulla samples) and Illumina HiSeq 2500 (isthmus samples) platforms were used to performed the Paired-end sequencing of 101-bp reads. The quality filtering was performed by seqyClean v1.3.12.
(https://bitbucket.org/izhbannikov/seqyclean/get/stable.zip) using a minimum of 26 Phred quality vector, and adaptor sequences from the Univec database (https://www.ncbi.nlm.nih.gov/ tools/vecscreen/univec/) were used as guides to remove possible contaminants. For the next steps, only high-quality pairedend sequences remained, and reads were mapped with Tophat v.2.0.8 [27] and Bowtie2 v2.1.0 [28] using the masked bovine genome (Bos taurus, UMD 3.1, NCBI). The mapping file was sorted using SAMTools v 0.1.18 [29] , and read counts were obtained using the script from HTSeq-count v0.5.4p2 (http://htseq.readthedocs.io/en/release_0.9.1/). DESEq v1.12.1 [30] from R/Bioconductor [31] was used to perform the differential expression analysis and, using the function "estimate Size Factors", the normalized counts were obtained (baseMean values are the number of reads divided by the size factor or normalization constant). The standard deviation along the baseMean values was also calculated for each transcript. In order to avoid artifacts caused by low expression profiles and high expression variance, only transcripts that had an average of baseMean > 5 and mean greater than the standard deviation were analyzed. The nbinom Test function on DESeq was used to test for differential expression and the threshold for evaluating significance was obtained by applying a P value of 0.05 FDR-Benjamini-Hochberg [32] . Finally, the Database for Annotation, Visualization, and Integrated Discovery [33] was used to perform the gene enrichment analysis separately for the ampulla or isthmus.
Protein extraction and multiplexed MMP array
Protein analyses were conducted only in isthmus samples because most changes on transcript abundance of ECM remodeling genes were detected in this region, according to transcriptomic data. About 20 mg of frozen isthmus samples (n = 4 for each group; please see details in the Statistical Analyses section) were ground in Next, membranes were incubated overnight at 4
• C with 1 ml of diluted sample containing 300 μg of total protein and the same cell lysis buffer used for the protein extraction step. Membranes were washed and incubated subsequently with a biotin-conjugated anticytokines cocktail for 2 h at RT. Next, membranes were washed and incubated with HRP-conjugated streptavidin for 2 h at RT. After additional washings, membranes were incubated with detection buffers and imaged using a ChemiDoc MP imaging system (Biorad, Hercules, CA, USA). Images were analyzed using spot-recognition analysis software (ImageJ). Signal intensities of each protein were normalized with the mean value of the positive control signal intensity. Positive control consisted of biotin-conjugated IgG protein printed in each membrane by the manufacturer, consistently from array to array.
Immunohistochemistry for collagen type I
Histological sections (4 μm) of both the ampulla (n = 5 of each group) and the isthmus (n = 5 of each group; please see details in the Statistical Analyses section) were deparaffinized, rehydrated, and subjected to enzymatic digestion with 0.4% pepsin (Sigma, USA) diluted in 0.5 N acetic acid for 30 min at 37 • C. After blocking endogenous peroxidase with 6% H 2 O 2 solution (Merck, USA) for 30 min, the slides were incubated in a humidified chamber overnight at 4
• C with the rabbit primary anti-type I collagen (#600-401-103, Rockland, USA; 1:3000). Slides were then incubated with the complex Super Picture Polymer Detection kit (Life Technologies, USA) for 30 min at 37
• C. After incubation, the reaction was visualized with 3'3 diaminobenzidine chromogen and counterstaining with Harris hematoxylin. Negative controls were performed replacing the primary antibody with normal rabbit IgG (#sc-2027, Santa Cruz Biotechnology, USA). For each sample, five optical fields from at least three tissue sections were photographed using light microscopy. Digital morphometric analysis for type I collagen quantification was performed using Image J and the Color deconvolution plugin [34] , as reported previously [35] . Identification of the immunostaining signal was performed in the whole tissue (i.e., ampulla or isthmus) as well as for each structural layer separately (i.e., tunica mucosa, tunica muscularis, and tunica serosa). Data are presented as the percentage of the whole tissue or percentage of mucosal area that showed positive staining for type I collagen.
Statistical analysis
Before laboratory analyses of the samples, animals were classified according to a ranking protocol that included the maximum diameter of the POF and E2 concentration at D-1, CL area, and P4 concentrations at D4. Because it was our interest to study the effect of the endocrine profile on oviductal physiology, we chose samples of the top-ranked animals in the LF-LCL group and the bottom ranked animals in the SF-SCL to perform all the analyses with the aim of having contrasting endocrine profiles (RNAseq analyses: three animals per group; MMP Arrays: four animals per group; IHQ analyses: five animals per group). The experiment was conducted as a completely randomized design. All statistical analyses were performed using SAS computational software, version 9.3 for Microsoft Windows (SAS Institute Inc., Cary, NC). Plasma concentrations of E2 and P4, follicle diameter, CL area, and protein quantification of the MMPs array were analyzed by ANOVA using the GLM procedure of SAS. Analyses of percentage of positive type I collagen areas was analyzed using the GLIMMIX procedure of SAS. The model included the fixed effects of group, region, and their interaction. Due to repeated measures within each cow (i.e., ampulla and isthmus), a repeated statement was used. A significant difference between groups was considered when P ≤ 0.05, whereas differences between P > 0.05 and P ≤ 0.10 were considered as approaching significance.
Results
Animal model
Results from the animal model used here were reported previously [8] . The hormonal manipulation protocol was successful in generating two groups of cows with distinct ovarian features and ovarian steroid endocrine profiles. To summarize, follicle diameter and E2 plasma concentration on D-1 and CL area and P4 plasma concentration on D4 were 38.81, 275.54, 65.68, and 75% greater for the LF-LCL compared to the SF-SCL group, respectively (P < 0.01).
ECM-related gene expression
A comprehensive analysis of the ampulla and isthmus transcriptome of cows in the LF-LCL and SF-SCL groups was reported previously [8] . A total of 692 and 590 genes showed differential expression between groups in ampulla and isthmus samples, respectively (adjusted P value < 0.1). Functional enrichment analysis revealed clusters with over-represented ontology terms and activation of pathways associated with ECM region, organization, and remodeling in the LF-LCL group, especially in the isthmus region (Table 1) . Enriched terms like ECM, extracellular region part, proteinaceous ECM, collagen, cell adhesion, and cell-matrix adhesion, among others, were found in the isthmus transcriptome of the LF-LCL group. In particular, transcripts upregulated in the isthmus region of cows ovulating larger follicles could be further classified as ECM components (Collagens), ECM remodelers [A Disintegrin and Metalloproteinase (ADAM)s and MMPs], and ECM-related GFs (potentially released from the ECM during the remodeling process). A list of these genes, their Log2Fold Change, and adjusted P value is available on was the only ECM-related gene that was downregulated in the LF-LCL group. Also, mRNA of 12 GFs that could be potentially sequestered in the ECM was upregulated in the LF-LCL group. In contrast, GFs that were transcribed similarly between groups in the isthmus included Transforming Growth Factor Beta 2 (TGFB2) and 3 (TGFB3), C-fos-induced growth factor (FIGF), Nerve Growth Factor (NGF), Heparin Binding EGF Like Growth Factor (HBEGF), Fibroblast Growth Factor 1 (FGF1) and 2 (FGF2), Heparin Binding Growth Factor (HDGF). Only minor changes in ECM-associated transcripts were found in the ampulla, in response to the sex-steroid milieu (data not shown).
MMPs and TIMPs protein expression
The results of the amino acid sequence alignment between human and bovine proteins resulted in adequate identities (ranging from 71 to 91%), similarities (79.8 to 95.9%), and gaps (0 to 7.7%) for the commercial kit target proteins, supporting the use of the human platform for detecting bovine orthologs. As for the MMP10 bovine protein, no sequence information was found on the NCBI protein database; therefore, its quantification was not considered in the present study. Signal intensities for MMP3, MMP8, MMP9, MMP13, and TIMP4 were 65.84, 43.50, 44.30, 76 .08, and 65.23% greater for the LF-LCL compared to the SF-SCL group, respectively (P < 0.05). Additionally, the protein expression of MMP1 and TIMP2 tended to be greater in the LF-LCL group (71.48 and 63.39%, respectively; P < 0.10; Figure 2 ).
Immunohistochemical evaluation of collagen content and tissue distribution
Immunohistochemistry analyses were performed to determine the distribution of type I collagen in the oviduct (Figure 3) . In both groups, type I collagen was detected in all the structural tunicae (mucosa, muscular, and serosa) as thick fibers. There were no differences in the type I collagen content when the tunica muscular and the tunica serosa were compared between groups or regions (data not shown). However, when type I collagen content was quantified in the tunica mucosa alone, there was a stronger signal in SF-SCL in comparison to LF-LCL groups on both regions (LF-LCL ampulla: 14.48 ± 5.21% and isthmus: 17.05 ± 2.52%; SF-SCL ampulla: 27.77 ± 1.70% and isthmus: 29.55 ± 3.58%).
Discussion
During the estrous cycle, hormonal changes prepare the reproductive tract for estrus, ovulation, fertilization, embryo development, and implantation. In cattle, global and specific changes in uterine morphology [36] , transcription [23, 37] , secretion, and protein composition [38, 39] in response to sex steroids were reported extensively. However, less information is available for the oviduct. This organ plays critical roles in gamete transport, fertilization, and early embryo development. Indeed, although it is usual to produce embryos in vitro, it is clear that quality and developmental potential is inferior than those of in vivo-produced embryos [40] [41] [42] . Molecular processes that occur in the oviduct during the estrous cycle and their relation to embryo receptivity need further understanding. Here, we evaluated gene and protein expression of ECM components and remodelers in the oviduct of cows that were treated to ovulate larger (LF-LCL group; associated with greater receptivity) or smaller follicles. We showed that the earlier and extended exposure to E2 and P4 during the periovulatory period, experienced by the LF-LCL animals, stimulated ECM remodeling. We speculate that differential ECM regulation may contribute to oviductal receptivity to the Downloaded from https://academic.oup.com/biolreprod/article-abstract/99/3/590/4962391 by OUP site access user on 04 October 2018 Table 2 . ECM-related genes detected in the RNAseq data of the isthmus of cows with distinct periovulatory milieus (SF-SCL vs LF-LCL; n = 3 cows/group). Fold changes were the ratio of the mean expression values of SF-SCL/LF-LCL. embryo, associated to the previously reported greater fertility of cows in the LF-LCL group. Growth and ovulation of a larger follicle stimulates transcription of molecules related to ECM remodeling. The present study is the first to show a global upregulation in the abundance of transcripts of ECM-related genes in response to modulation of the periovulatory endocrine milieu. Other studies have described changes in the bovine oviductal transcriptome using different experimental models. Bauersachs et al. [43] compared the transcriptome of ipsilateral vs. contralateral oviducts at D 3.5 after standing heat. They reported a series of molecular functional categories that were upregulated in the ipsilateral side, including cell-surface proteins, cell-cell interaction proteins, members of signal transduction pathways, immune-related proteins, and enzymes. While investigating the changes in oviductal gene expression during the estrous cycle in a subsequent study, Bauersachs et al. [44] reported enrichment of molecular processes such as protein modification and secretion, endocytosis, regulation of transcription, signaling pathways, and immune-related functions. Additionally, Cerny et al. [45] reported a series of molecular pathways related to cholesterol biosynthesis, oxidative phosphorylation, cancer and cell cycle, receptor signaling pathway, and cell-cell adhesion, among others, which were altered either by the estrous-cycle stage (i.e., follicular vs. luteal) or by the oviductal region (i.e., ampulla vs. isthmus). Moreover, other studies have shown that the oviductal transcriptome is also responsive to the presence of sperm cells or embryos [46] [47] [48] [49] [50] . Nevertheless, none of the experimental models employed in the above-mentioned studies have shown a relationship between the factors tested and regulation of ECM remodeling genes. In the present model, modulation of the size of the ovulatory follicle led to contrasting patterns of ovarian steroid hormones secretion. Specifically, cows in the LF-LCL group ovulated larger follicles, had earlier and more prominent rise in estradiol and, consequently, greater, postovulation progesterone concentrations. Thus, upregulation of ECM-related genes in the LF-LCL group suggest that ECM remodeling initiates earlier in response to the earlier and more prominent rise in ovarian steroids. Furthermore, the LF-LCL is associated with greater fertility [10] . This supports the notion of a positive association between upregulation of ECM remodeling genes and fertility. Changes in the expression of ECM-related genes were also observed in an alternative fertility model. Tanaka et al. [51] compared the oviductal transcriptome of young (30-50 months; greater fertility) vs. aged (more than 120 months; lower fertility) cows. They reported that, in aged oviductal epithelial cells, there was an inhibition of ECM-related genes, such as decorin (DCN), periostin (POSTN), COL1A1, Actin alpha 2 (ACTA2), and Biglycan (BGN), supporting the proposed relationship between the regulation of ECM-related molecules in the oviduct and fertility. In summary, the oviductal transcriptome can be altered by many factors, such as oviductal region, side relative to the POF or CL, presence of embryo and gametes, and fertility. However, disturbances in the expression of ECM-related genes were clearly observed when distinct fertility phenotypes in cows were compared. * Significant difference between groups ( * P < 0.05; * * P < 0.10).
Group of compounds
Growth and ovulation of a larger follicle stimulate protein expression of MMPs and TIMPs in the isthmus. In the present study, the protein abundance of members of the ECM remodeling pathway was measured using an antibody array. Out of the nine proteins evaluated, seven were more abundant in the LF-LCL group. ECM remodeling occurs in several tissues during physiological and pathological processes as well as during tissue development [13, 14] . During early embryo development, the endometrial ECM undergoes remodeling by changing its composition as part of a necessary mechanism to promote embryo implantation [19, 20] . A potential implication of ECM remodeling is the release of stored GFs [16] that may favor embryo development, particularly during the preimplantation stage [52, 53] . Gabler et al. [54] reported that protein abundance and activity of ECM remodelers in the bovine oviduct are regulated in response to the stage of the estrous cycle. These authors showed the active presence of two major ECM remodeling pathways: the matrix metalloproteinase system and the plasminogen system. They concluded that enzymes such as uPA, PAI-1, TIMPs, MMP-1, and MMP-2 are produced and secreted by bovine oviductal cells. Those enzymes could act by protecting gametes and the early embryo from proteolytic degradation and releasing heparin-binding GFs from the epithelium surface, thus stimulating embryo development. Here, we speculate that a greater remodeling in the isthmus of LF-LCL cows could enrich the luminal environment with embryotrophic GFs.
Growth and ovulation of a larger follicle stimulate type I collagen degradation in the tunica mucosa of ampulla and isthmus. In the isthmus, the tunica mucosa of LF-LCL cows expressed approximately 50% less type I collagen than that of SF-SCL cows. This result is consistent with the MMP protein profiling obtained in the . The original microphotography of the oviductal tissue stained for collagen I was processed using the "Color deconvolution" algorithm to extract the DAB staining (collagen I). Then, a binary image where collagen I staining is marked as black was created from which mucosal and total stained area were quantified. All procedures were made using image J software and the Color deconvolution plugin. (C) Mean ± S.E.M. of the percentage of area (arbitrary units) that showed positive staining for type I collagen. ab indicates statistical differences between groups and xy indicates statistical differences between regions. current study. Out of the major four type I collagen proteases (MMP1, MMP2, MMP8, and MMP13), three of them were more abundant in the oviduct of LF-LCL cows suggesting that the observed low abundance of type I collagen is probably a consequence of the greater abundance of type I collagen proteases reported in this study. Additionally, the relationship between sex steroids and oviductal MMP expression has also been shown in several species [54] [55] [56] . In particular, Gabler et al. [54] evaluated activity and quantity of MMPs using gelatin zymograms in cows, and showed that these proteins are more active during the follicular phase (days 1-5 and 19-21 of the estrous cycle), when circulating concentrations of estradiol are elevated, thus suggesting a positive regulation of MMPs by estradiol and supporting our data. In this context, modulating the composition of the ECM may also represent a mechanism of phenotype regulation for the surrounding cell types by providing an environment that is more or less permissive to biological processes such as proliferation, migration, and differentiation [23, 57, 58] . It is also possible that a less rigid mucosa, associated with less type I collagen abundance, provides a physical environment that is more adequate for embryo growth and transport.
In summary, the present study showed that the ECM remodeling process is more intense and probably occurs earlier in the oviduct of greater fertility cows when the embryo is being transported from the oviductal lumen into the uterine environment (i.e., D4). ECM remodeling could help release GFs from the ECM and control rigidity of the oviductal mucosa to benefit the development and survival of the embryo. New studies are needed to compare the composition of the oviductal fluid, especially GFs availability, in models or conditions that simulate distinct fertility conditions in cattle.
